-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SCnrFujjwyl+yyT5sIJiCWTOj1G/mTIy7hNQS+m1VKJW9T/4ZCgsZ6U3ULFOF3Fy NUPLLohbYvUqegpYo/BS7A== 0000014272-06-000101.txt : 20060309 0000014272-06-000101.hdr.sgml : 20060309 20060309170957 ACCESSION NUMBER: 0000014272-06-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060307 FILED AS OF DATE: 20060309 DATE AS OF CHANGE: 20060309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEUNG SANDRA CENTRAL INDEX KEY: 0001199294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 06676807 MAIL ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 4 1 leu536.xml X0202 4 2006-03-07 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001199294 LEUNG SANDRA 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 Vice President and Secretary Common Stock, $0.10 par value 2006-03-07 4 A 0 3510 22.73 A 14608.00 D Common Stock, $0.10 par value 3584.02 I By BMY Savings & Investment Program Option (right to buy) 22.73 2006-03-07 4 A 0 14560 0 A 2016-03-06 Common Stock, $0.10 par value 14560.00 14560.00 D Shares consist of restricted stock that vests 25% on each of the first, second, third and fourth anniversaries of the grant date. Based on a plan statement as of the end of the most recent fiscal quarter. Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. /s/ Leung, Sandra 2006-03-09 -----END PRIVACY-ENHANCED MESSAGE-----